Randall Schreck

4.7k total citations · 1 hit paper
13 papers, 2.3k citations indexed

About

Randall Schreck is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Randall Schreck has authored 13 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Randall Schreck's work include Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Treatment and Pharmacology (3 papers). Randall Schreck is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Treatment and Pharmacology (3 papers). Randall Schreck collaborates with scholars based in United States, Germany and France. Randall Schreck's co-authors include Cho Tang, Gerald McMahon, Li Sun, Laura K. Shawver, Werner Risau, Thomas Powell, Xueyan Wang, K. Peter Hirth, A. Ullrich and T. Annie T. Fong and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Journal of Allergy and Clinical Immunology.

In The Last Decade

Randall Schreck

13 papers receiving 2.2k citations

Hit Papers

SU5416 is a potent and se... 1999 2026 2008 2017 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.
    1999 885 citations T. Annie T. Fong, Laura K. Shawver et al. PubMed profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Randall Schreck 1.5k 686 469 318 298 13 2.3k
Richard Kendall 1.8k 1.2× 837 1.2× 476 1.0× 268 0.8× 313 1.1× 43 3.0k
Karl‐Heinz Thierauch 1.0k 0.7× 908 1.3× 409 0.9× 502 1.6× 369 1.2× 33 2.5k
Jane Kendrew 1.5k 1.0× 1.1k 1.6× 561 1.2× 638 2.0× 123 0.4× 33 2.7k
Nila U. Parikh 1.5k 1.0× 1.2k 1.8× 522 1.1× 314 1.0× 141 0.5× 39 2.5k
Sébastien Jeay 1.1k 0.8× 631 0.9× 320 0.7× 176 0.6× 166 0.6× 46 1.8k
T. Annie T. Fong 1.3k 0.9× 523 0.8× 555 1.2× 231 0.7× 74 0.2× 10 1.8k
Raymond M. Shaheen 1.3k 0.9× 753 1.1× 693 1.5× 363 1.1× 194 0.7× 20 2.0k
Toshimitsu Uenaka 797 0.5× 652 1.0× 258 0.6× 509 1.6× 302 1.0× 33 1.8k
Cinzia Lanzi 1.5k 1.0× 895 1.3× 317 0.7× 249 0.8× 62 0.2× 73 2.4k
Akiko Kokubu 2.2k 1.4× 649 0.9× 594 1.3× 404 1.3× 125 0.4× 29 3.0k

Countries citing papers authored by Randall Schreck

Since Specialization
Citations

This map shows the geographic impact of Randall Schreck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall Schreck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall Schreck more than expected).

Fields of papers citing papers by Randall Schreck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall Schreck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall Schreck. The network helps show where Randall Schreck may publish in the future.

Co-authorship network of co-authors of Randall Schreck

This figure shows the co-authorship network connecting the top 25 collaborators of Randall Schreck. A scholar is included among the top collaborators of Randall Schreck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall Schreck. Randall Schreck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lin, Chung‐Wu, Wu‐Chou Su, Chia‐Jui Yen, et al.. (2011). A phase I dose-escalation study of the polo-like kinase 1 inhibitor volasertib (BI 6727) with two different dosing schedules in patients with advanced solid malignancies.. Journal of Clinical Oncology. 29(15_suppl). 3046–3046. 3 indexed citations
2.
3.
Sornasse, Thierry, Wenming Hong, Randall Schreck, et al.. (2005). Daclizumab in vitro inhibits the secretion of pro-asthmatic and pro-inflammatory cytokines by activated T cells. Journal of Allergy and Clinical Immunology. 115(2). S73–S73. 4 indexed citations
4.
Christensen, James G., Randall Schreck, Jon Burrows, et al.. (2003). A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.. PubMed. 63(21). 7345–55. 421 indexed citations
5.
Christensen, James G., Randall Schreck, Emily Chan, et al.. (2001). High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivo.. PubMed. 7(12). 4230–8. 60 indexed citations
6.
Mendel, Dirk B., Randall Schreck, David C. West, et al.. (2000). The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.. PubMed. 6(12). 4848–58. 173 indexed citations
7.
Sun, Li, Ngoc Quang Tran, Stevan R. Hubbard, et al.. (2000). Identification of Substituted 3-[(4,5,6,7-Tetrahydro-1H-indol-2-yl)methylene]- 1,3-dihydroindol-2-ones as Growth Factor Receptor Inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rβ Tyrosine Kinases. Journal of Medicinal Chemistry. 43(14). 2655–2663. 99 indexed citations
8.
9.
Sun, Li, Ngoc Quang Tran, Congxin Liang, et al.. (1999). Design, Synthesis, and Evaluations of Substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF Receptor Tyrosine Kinases. Journal of Medicinal Chemistry. 42(25). 5120–5130. 213 indexed citations
10.
McMahon, Gerald, Harald App, Randall Schreck, et al.. (1996). Flk-1 as a target for tumor growth inhibition.. PubMed. 56(15). 3540–5. 279 indexed citations
11.
Powell, Thomas, Randall Schreck, Audie Rice, et al.. (1995). A Tumor-Derived Protein which Provides T-Cell Costimulation through Accessory Cell Activation. Journal of Immunotherapy. 17(4). 209–221. 49 indexed citations
12.
Schreck, Randall, Frank Schnieders, Cornelia Schmutzler, & Josef Köhrle. (1994). Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.. The Journal of Clinical Endocrinology & Metabolism. 79(3). 791–798. 98 indexed citations
13.
Schreck, Randall, et al.. (1989). Effect of the Barring Gene on Eye Pigmentation in the Fowl. Pigment Cell Research. 2(3). 191–201. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Kendall Breakdown of academic impact, for papers by Karl‐Heinz Thierauch Breakdown of academic impact, for papers by Jane Kendrew Breakdown of academic impact, for papers by Nila U. Parikh Breakdown of academic impact, for papers by Sébastien Jeay Breakdown of academic impact, for papers by T. Annie T. Fong Breakdown of academic impact, for papers by Raymond M. Shaheen Breakdown of academic impact, for papers by Toshimitsu Uenaka Breakdown of academic impact, for papers by Cinzia Lanzi Breakdown of academic impact, for papers by Akiko Kokubu
Rankless by CCL
2026